
Rholence Pharmaceuticals Private Limited
Pharmaceutical company dealing in medicinal and related products since 2010.
Pharmaceutical company dealing in medicinal and related products since 2010.
Rholence Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2010 and has a history of 15 years and two months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.89 M.
Rajendra Dhole and Pratima Dhole serve as directors at the Company.
Nagpur, Maharashtra, India
+91-XXXXXXXXXX
U24100MH2010PTC200028
200028
Private Limited Indian Non-Government Company
12 Feb 2010
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajendra Dhole ![]() | Director | 12-Feb-2010 | Current |
Pratima Dhole ![]() | Director | 12-Feb-2010 | Current |
Rholence Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 6.3% increase. The company also saw a substantial improvement in profitability, with a 130.54% increase in profit. The company's net worth moved up by a moderate rise of 0.6%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Rholence Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹0.89 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
08 Jun 2020 | Others | ₹0.09 M | Open |
28 Feb 2019 | Others | ₹0.80 M | Open |
Unlock and access historical data on people associated with Rholence Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rholence Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rholence Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rholence Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Rholence Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
A charge with Others amounted to Rs. 0.09 M with Charge ID 100358637 was registered on 08 Jun 2020.
A charge with Others amounted to Rs. 0.80 M with Charge ID 100248337 was registered on 28 Feb 2019.
Rajendra Sheshrao Dhole was appointed as a Director was appointed as a Director on 12 Feb 2010 & has been associated with this company since 15 years 2 months .
Pratima Rajendra Dhole was appointed as a Director was appointed as a Director on 12 Feb 2010 & has been associated with this company since 15 years 2 months .
Rholence Pharmaceuticals Private Limited was incorporated on 12 Feb 2010.
The authorized share capital of Rholence Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Rholence Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Rholence Pharmaceuticals Private Limited is 103, New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla India, Nagpur, Maharashtra, 440024.
The corporate identification number (CIN) of Rholence Pharmaceuticals Private Limited is U24100MH2010PTC200028 and the company number is 200028 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2021, the revenue trend for Rholence Pharmaceuticals Private Limited has risen by 6.30%.
The financial reports for the fiscal year 2021 indicates that The net worth of Rholence Pharmaceuticals Private Limited has experienced an upsurge of 0.60%.
As per the financial statements for fiscal Year 2021, The total open charges for Rholence Pharmaceuticals Private Limited amount to ₹ 0.89 M.
The most recent Balance Sheet for Rholence Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
KD
RD